NEGpre-221 pre-222pre-221/222 NEG DMSO 100 nM Fulvestrant for 72h Figure S1. Cell morphology of MCF7 cells after treatment with fulvestrant, with or without.

Slides:

Advertisements

Similar presentations

Fig. S1 Cytoplasm V c Periplasm V pp Microenvironment V e D pp AiAi A pp AeAe k IMOM * * * D.

Advertisements

Step 1 Step 4 Step 3 Step 2 Step 7 Step 6 Step 8 Step 5 73 miRNAs 62 miRNAs 38 miRNAs 7 miRNAs 1 miRNA Figure S1: Study Workflow.

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.

Fig. S1 Fig. S1 Correlation between microarray and qRT-PCR expression analyses. The linear regression compares expression ratios of salinity to control.

WT GRX-V GRX-VI GRX-VII 12-day-old seedlings on MS medium20-day-old seedlings on soilrite Mature plants in pots Supplementary Fig. S1 Phenotype of wild-type.

Figure S1. In absence of Rvb1, treatment with various DNA damaging agents results in increased phosphoH2AX. HeLa cells were transfected with indicated.

Cell number (% vehicle control) cisplatin concentration (µM)gefitinib concentration (µM) cell number expression level (fluorescence intensity)

AB Figure S1 DNA content (% of control) **. MCF7:PF +E2 1 MCF7:PF +E2 2 MCF7:PF +E2 3 MCF7:PF +4OHT 1 MCF7:PF +4OHT 2 MCF7:PF +4OHT 3 MCF7:PF +ICI 1 MCF7:PF.

Suppl. Fig.1 KEGG B-cell receptor signaling pathway. Added by YLW.

Suppl. Figure 1 A B Suppl. Figure 1. Relative (A) miR-21 and (B) miR-224 expression levels in HCC tumors in different stages (I,II,III,IV) assessed by.

Supplementary Materials and Methods Real-time RT-PCR Genomic DNA was isolated from washed cell pellets of eight biliary tract cancer cell lines (SNU-245,

Figure S1. RNA-seq results for caveolin-1 (Cav1). Upper panel: UCSC genome browser view. Lower panel: quantification o f Cav1 expression based on RNA-seq.

Mandal CC et al Supplementary Fig. S1. Increased expression of CSF-1 in human breast cancer cells. (A) The conditioned media from normal human breast epithelial.

Marker (%) Normal EPCs Mean ± SM (%) MMD EPCs Mean ± SM (%) CD ± ± 6.8 KDR27.3 ± ± 8.90 CD ± ± 3.93 CD ±

Supplemental Figure 1: ER  expression in MCF-7 cells. MCF-7 cells were either pre-treated with ICI 182,780 (lanes 5-8) or EtOH (vehicle, lanes 1-4) for.

Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.

Relative to 18S rRNA Supplementary Figure S1. H2228 and H3122 cells express HK1 and HK2 mRNAs. The qPCR was performed as described in Figure 5 and the.

From: Endothelial TWIST1 Promotes Pathological Ocular Angiogenesis

Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C Kristine P. Malabanan,

Volume 70, Issue 8, Pages (October 2006)

Epidermal Growth Factor Promotes Proliferation and Migration of Follicular Outer Root Sheath Cells via Wnt/β-Catenin Signaling Cell Physiol Biochem 2016;39:

a b SUM149PT Motility Invasion C V C V

IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.

Volume 19, Issue 9, Pages (September 2017)

MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation G.

A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation Lily Mahapatra, Neal Andruska, Chengjian Mao,

Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes Ying Shan, Jianyu Zheng, Richard.

Volume 23, Issue 3, Pages (April 2018)

Volume 9, Issue 2, Pages (August 2017)

Supplemental Information

Masanori Ono, M. D. , Ph. D. , Ping Yin, Ph. D. , Antonia Navarro, M

Recombinant OPCML protein effect in vitro.

Epidermal Growth Factor Induces Fibronectin Expression in Human Dermal Fibroblasts via Protein Kinase C δ Signaling Pathway Yoshihiro Mimura, Hironobu.

MiR-142-3p is a novel regulator of cell viability and proinflammatory signalling in endometrial stroma cells Christin Susanna Kästingschäfer, Sebastian.

Volume 26, Issue 1, Pages (January 2007)

Expression and regulation of MD-2s.

Linda Vi, Stellar Boo, Samar Sayedyahossein, Randeep K

Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C

Volume 142, Issue 3, Pages e2 (March 2012)

Transforming growth factor (TGF)-β1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation.

Keratinocyte Growth Inhibition by High-Dose Epidermal Growth Factor Is Mediated by Transforming Growth Factor β Autoinduction: A Negative Feedback Mechanism.

SiRNA-Targeting Transforming Growth Factor-β Type I Receptor Reduces Wound Scarring and Extracellular Matrix Deposition of Scar Tissue Yi-Wen Wang, Nien-Hsien.

Dynamic change of transcription pausing through modulating NELF protein stability regulates granulocytic differentiation by Xiuli Liu, Aishwarya A. Gogate,

Volume 19, Issue 9, Pages (September 2017)

Volume 10, Issue 8, Pages (March 2015)

Estrogenic regulation of testicular expression of stem cell factor and c-kit: implications in germ cell survival and male fertility Sara Correia, M.S.,

MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites to Alter the Breast Cancer Cell Transcriptome Hector L. Franco, Anusha Nagari, W. Lee Kraus

Volume 59, Issue 2, Pages (July 2015)

Discoidin Domain Receptor 2–microRNA 196a–Mediated Negative Feedback against Excess Type I Collagen Expression Is Impaired in Scleroderma Dermal Fibroblasts

MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2 Ning Xu, Petter Brodin, Tianling Wei, Florian.

MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells Duc-Hiep Bach,

Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways

Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.

Volume 20, Issue 4, Pages (October 2011)

JNK Regulates Autocrine Expression of TGF-β1

Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc

Insulin-Like Growth Factor-Binding Protein 7 Regulates Keratinocyte Proliferation, Differentiation and Apoptosis Janna Nousbeck, Ofer Sarig, Nili Avidan,

Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability

Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells Dario Antonini, Monia T. Russo, Laura.

Volume 13, Issue 12, Pages (December 2015)

MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway

Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.

Protein Kinase C-Dependent Upregulation of miR-203 Induces the Differentiation of Human Keratinocytes Enikö Sonkoly, Tianling Wei, Elizabeth Pavez Loriè,

USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1

Volume 70, Issue 8, Pages (October 2006)

Effects of Hepatocyte Growth Factor on the Expression of Type I Collagen and Matrix Metalloproteinase-1 in Normal and Scleroderma Dermal Fibroblasts

TFAP2A knockdown inhibits cell growth by targeting HIF-1α signaling.

Activation of Wnt signaling pathway in trastuzumab-resistant cell lines. Activation of Wnt signaling pathway in trastuzumab-resistant cell lines. A, bar.

Presentation transcript:

NEGpre-221 pre-222pre-221/222 NEG DMSO 100 nM Fulvestrant for 72h Figure S1. Cell morphology of MCF7 cells after treatment with fulvestrant, with or without pre-221 and/or transfection (Magnification 20× objective).

Figure S2. p27 Kip1 and ERα protein level in MCF7 cells. 24 hours after transfection with pre-miR-221 (pre- 221) and/or pre-miR-222 (pre-222), cells were treated with 10 nM fulvestrant for 2 days and subjected to immunoblotting analysis. GAPDH p27 ERα nM Fulvestrant Scramble pre-221 pre-222

GAPDH p27 MCF7 MCF7-F NEG si-221/222 MCF7-F Figure S3. p27 Kip1 protein level in MCF7, MCF7-F cells, and MCF7-F cells transfected with negative control (NEG) or antagomirs (si-221/222) for 72 hours.

Figure S4. Expression level of miR-221/222 in fulvestrant-resistant MCF7-F cells after knockdown of miR-221 (left panel) or miR-222 (right panel) using 2-O-Me-antagomirs. (mean±SE, n=3). **P < **

Figure S5. Clonogenic activity of MCF7 and fulvestrant-resistant MCF7-F cells. (mean±SE, n=3). **P < **

GAPDH p27 NEG si-221 si-222 Figure S6. p27 Kip1 mRNA (left) and protein level (right l) in MCF7-F cells transfected with si-221 or si-222 for 72 hours. (mean±SE, n=2, two independent experiments). **P < 0.01.

Downregulated by si-221 (688) Downregulated by si-222 (685) 224 Upregulated by si- 221 (919) Upregulated by si- 222 (601) 428 Figure S7. Venn diagrams showing the number of probes regulated by miR-221 and miR-222 in fulvestrant- resistant MCF7-F cells. A. Probes upregulated by si-221 or si-222; B. Probes downregulated by si-221 or si-222. A B

Figure S8. Fold-change of pathway activities in fulvestrant-resistant MCF7-F cells compared to MCF7 cells. Cignal Finder Cancer Pathway Reporter assay (SABiosciences Corporation, Frederick, MD) was performed according to the manufacturers instruction. (mean±SE, n=4). **P < **

Figure S9. qPCR results showing the time-course gene expression after transfection of MCF7 cells with miR-221/222 (solid lines), compared with scramble (dotted lines).

β-catenin GAPDH Scramble si-221 si-222 si-221/222 MCF7-F Figure S10. Immunoblotting result of β-catenin in MCF7-F cells after antagomiR treatment.

** Figure S11. Cell proliferation assay of MCF7 cells. A. Cells were cultured in normal growth medium for 4 days. B. Cells were cultured in estrogen-free medium for 7 days.. (mean±SE, n=6). **P < AB

Figure S12. Dose dependent growth inhibition of MCF7 (black bars) and MCF7-F cells (gray bars) by TGF-β1 treatment. Cell numbers were determined using MTT assay and normalized to vehicle-treated cells.

PTEN MCF7 ERα p27 GAPDH NTpre-scramble pre-221 pre-222 pre-221/222 PTEN GAPDH MCF7-F NT NEG si-221 si-222 si-221/222 p27 Figure S13. Immunoblotting results of PTEN protein level in MCF7 and fulvestrant-resistant MCF7-F (PTEN antibody obtained from Cell Signaling Technology, Inc., Danvers, MA)